40
Participants
Start Date
January 6, 2020
Primary Completion Date
June 6, 2027
Study Completion Date
June 6, 2027
STS
"M0-M6 (run-in phase): medical care and follow-up as usual~M6-M12 (STS phase):~* Patients with iPPSD2 will be treated with subcutaneous infusion using a portable pump.~* Patients with dermatomyositis or systemic sclerosis will be treated with repeated injections every two weeks.~Patients will receive a maximal total number of 11 STS injections. M12: final visit (V5): clinical evaluation, photograph and CT scan of the treated lesion, pain and quality of life evaluation."
RECRUITING
CHU de Toulouse, Toulouse
RECRUITING
CHU de BORDEAUX, Bordeaux
NOT_YET_RECRUITING
Hospice Civil de Lyon, Bron
RECRUITING
ApHp - hôpital Lariboisière, Paris
NOT_YET_RECRUITING
Hôpital de la Pitié Salpétriêre, Paris
NOT_YET_RECRUITING
CHU de ROUEN, Rouen
RECRUITING
CHU de Limoges, Limoges
RECRUITING
ApHp - Hôpital Bicêtre, Le Kremlin-Bicêtre
University Hospital, Limoges
OTHER